Privia Health Group/$PRVA
1D1W1MYTD1Y5YMAX
Capital at risk
About Privia Health Group
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
- Ticker
- $PRVA
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 1,226
- Headquarters
- Arlington, United States
- Website
- www.priviahealth.com
PRVA Metrics
BasicAdvanced
$2.5B
90.52
$0.22
0.90
-
Price and volume
Market cap
$2.5B
Beta
0.9
52-week high
$28.82
52-week low
$19.53
Average daily volume
1.2M
Financial strength
Current ratio
1.616
Quick ratio
1.555
Long term debt to equity
0.008
Total debt to equity
0.01
Profitability
EBITDA (TTM)
56.936
Gross margin (TTM)
10.03%
Net profit margin (TTM)
1.19%
Operating margin (TTM)
1.90%
Effective tax rate (TTM)
39.69%
Revenue per employee (TTM)
$1,920,000
Management effectiveness
Return on assets (TTM)
2.03%
Return on equity (TTM)
4.31%
Valuation
Price to earnings (TTM)
90.523
Price to revenue (TTM)
1.044
Price to book
3.2
Price to tangible book (TTM)
7.2
Price to free cash flow (TTM)
18.78
Free cash flow yield (TTM)
5.32%
Free cash flow per share (TTM)
1.057
Growth
Revenue change (TTM)
24.10%
Earnings per share change (TTM)
99.55%
3-year revenue growth (CAGR)
16.10%
3-year earnings per share growth (CAGR)
-8.74%
What the Analysts think about PRVA
Analyst ratings (Buy, Hold, Sell) for Privia Health Group stock.
Analyst projections of the future price of Privia Health Group stock.
Bulls say / Bears say
2Q’26 GAAP revenue rose 21.4% year-over-year to $632.6 million, driven by strong adoption of its value-based care platform (Bitget News)
2Q’26 GAAP net income was $9 million, more than double the prior year’s $2.7 million, reflecting improved operational leverage (Bitget News)
Raised full-year 2026 guidance: revenue now guided to $2.35 billion–$2.45 billion and adjusted EBITDA to $145 million–$155 million, underscoring management’s confidence in sustained growth (Bitget News)
Q2 non-GAAP adjusted EPS of $0.19 missed the FactSet consensus of $0.24, prompting a 13% share price decline and highlighting profitability execution risks (Yahoo Finance)
Company disclosures note potential decreases in reimbursement rates by governmental and third-party payers could constrain revenue and margins, underscoring exposure to payer policy shifts (SEC)
Company warns of challenges in successfully establishing a presence in new geographic markets, signaling integration and execution risk for recent expansions like New Jersey (SEC)
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2026.
PRVA Financial Performance
Revenues and expenses
PRVA Earnings Performance
Company profitability
Upcoming events
No upcoming events
PRVA News
AllArticlesVideos
Funds containing PRVA
AllUSDGBPEUR
Fund name | Fund size | $PRVA weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.14% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.14% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.08% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.05% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.